2 Results for "

relapsed and/or refractory indolent lymphoma

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "relapsed and/or refractory indolent lymphoma" in MCE Product Catalog:

Cat. No.: HY-P99613
CAS No.: 2231068-83-8
Synonyms: MK-4280; Mavezelimab

Target:  

LAG-3

Research Areas:  

Cancer

Favezelimab (MK-4280) is a humanized monoclonal antibody targeting LAG-3. Favezelimab blocks the interaction between LAG-3 and its ligand, MHC class II molecules. Favezelimab is applicable to research on relapsed/refractory classical Hodgkin lymphoma, relapsed/refractory diffuse large B-cell lymphoma, and relapsed/refractory indolent B-cell lymphoma . For the isotype control of Favezelimab, refer to Human IgG4 (S228P) kappa, Isotype Control (HY-P99003).
loading...
    loading...
Cat. No.: HY-P992445

Target:  

CD20

Research Areas:  

Cancer

PRO131921 is a humanized IgG1 anti-CD20 antibody, with antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity activities. PRO131921 acts as an anti-tumor agent. PRO131921 can be used for the research of indolent non-Hodgkin lymphoma and relapsed and refractory indolent lymphoma .
loading...
    loading...